These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23064917)

  • 1. Motherisk update. Is ondansetron safe for use during pregnancy?
    Koren G
    Can Fam Physician; 2012 Oct; 58(10):1092-3. PubMed ID: 23064917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating morning sickness in the United States--changes in prescribing are needed.
    Koren G
    Am J Obstet Gynecol; 2014 Dec; 211(6):602-6. PubMed ID: 25151184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing recurrence of severe morning sickness.
    Koren G; Maltepe C
    Can Fam Physician; 2006 Dec; 52(12):1545-6. PubMed ID: 17279232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial.
    Oliveira LG; Capp SM; You WB; Riffenburgh RH; Carstairs SD
    Obstet Gynecol; 2014 Oct; 124(4):735-742. PubMed ID: 25198265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia.
    Doggrell SA; Hancox JC
    Expert Opin Drug Saf; 2013 May; 12(3):421-31. PubMed ID: 23578248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.
    Taylor LG; Bird ST; Sahin L; Tassinari MS; Greene P; Reichman ME; Andrade SE; Haffenreffer K; Toh S
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):592-596. PubMed ID: 28220993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label use of ondansetron in pregnancy in Western Australia.
    Colvin L; Gill AW; Slack-Smith L; Stanley FJ; Bower C
    Biomed Res Int; 2013; 2013():909860. PubMed ID: 24396830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron looks safe in pregnancy, so far.
    BMJ; 2013 Mar; 346():f1387. PubMed ID: 23468289
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
    Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
    JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new pharmacologic treatment for nausea and vomiting of pregnancy.
    Fantasia HC
    Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy.
    Koren G
    Expert Opin Drug Saf; 2017 Nov; 16(11):1227-1234. PubMed ID: 28749713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?
    Persaud N; Chin J; Walker M
    J Obstet Gynaecol Can; 2014 Apr; 36(4):343-348. PubMed ID: 24798673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study.
    Pope E; Maltepe C; Koren G
    J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness--a new morning for American women.
    Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(2):e161-2. PubMed ID: 23863487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nausea and vomiting in pregnancy: A place for ondansetron?].
    Coulm B
    Gynecol Obstet Fertil Senol; 2021 Dec; 49(12):947-950. PubMed ID: 34700033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.
    Madjunkova S; Maltepe C; Koren G
    Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
    BMC Pregnancy Childbirth; 2015 Mar; 15():59. PubMed ID: 25884778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.